You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
聯合醫務(00722.HK)新醫療中心開業 與港安協議下第三個合作項目
阿思達克 03-08 15:05
聯合醫務(00722.HK)及港安醫院開辦的港安醫療中心/銅鑼灣 /普康醫學影像及化驗中心(利園二期)於今日(8日)開業,為大眾提供一站式醫療及影像診治服務。這是集團自去年1月與港安醫療簽署策略性合作協議後,雙方深化合作的第三個項目。 該中心面積約1.4萬平方呎,將提供整全女性健康、兒童及青少年全人發展評估、家庭醫學、皮膚及整形外科服務、疾病營養諮詢及飲食治療、物理治療及復康服務、其他專科及門診服務。 首席投資與項目高級總監張志華指,集團去年投資約一億元購買機器,而一般機器可使用7至8年。在2023至24年共有四個新設項目,當中,最新位於利園二期的影像及化驗中心的投資額約為3,000萬元,而位於尖沙咀的醫學中心涉及投資約5,000萬元。 副主席及聯席行政總裁孫文堅表示,今年暫時未有再開新醫療中心的計劃。董事總經理及執行董事郭卓君補充,由於設立新中心需要籌備一年,因此需要視乎生意狀況及升級需要。 郭卓君指,公司有考慮進行收購,亦有充足現金流,但對此持審慎態度,亦會注重對方的營運團隊。她提到,中醫是集團會考慮的其中一個發展方向。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account